|
|
Application of miR-9-5p in targeting UBE4B in regulating hypoxia-induced transcription factor 1α ubiquitination-mediated Warburg effect in glioma cells |
ZHANG Jingjing YALIKUN Nu’er’aihemaitijiang DU Peng |
Department of Neurosurgery, the Second Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi 830063, China |
|
|
Abstract Objective To explore the regulation and mechanism of miR-9-5p on Waburg effect in glioma. Methods Thirty patient’s glioma and paracancerous tissue samples diagnosed from May 2018 to October 2020 in the Second Affiliated Hospital of Xinjiang Medical University were selected. A control group, a miR-9-5p overexpression group, and a miR-9-5p inhibitor group were established. Quantitative real-time PCR was used to detect the expression of miR-9-5p and its correlation with the expression of glycolysis-related genes. Construction of ectopic tumor models and in vitro cell experiments, using quantitative real-time PCR, Western blot, glucose uptake analysis, lactic acid production detection and cell viability detection to determine the impact of miR-9-5p on glioma and Warburg effect, while the dual luciferase reporter gene was used to detect the targeting relationship between miR-9-5p and UBE4B. Results The expressions of Hypoxia inducible factor-1α(HIF1α) protein, glucose transporter 1 (Glut1), human hexokinase-2 (HK2), lactate dehydrogenase (LDHA) and vascular endothelial growth factor (VEGF) in the miR-9-5p overexpression group were significantly higher than those in the control group, and the differences were statistically significant (P < 0.05); while the mRNA level of HIF1α was not statistically significant (P > 0.05). The expressions of HIF1α protein, Glut1, HK2, LDHA and VEGF in the miR-9-5p inhibitor group were significantly lower than those in the control group, and the differences were statistically significant (P < 0.05); while the mRNA levels of HIF1α were not statistically significant (P > 0.05). Compared with the control group, the miR-9-5p overexpression group significantly enhanced metabolism and metastasis (P < 0.05), while the miR-9-5p inhibitor group significantly reduced glucose uptake and lactate production in U251 cells (P < 0.05). The cell viability of the miR-9-5p overexpression group was significantly higher than that of the control group after treatment for 24 h and 48 h, and the differences were statistically significant (P < 0.05); compared with the control group, the cell viability of the miR-9-5p inhibitor group decreased significantly at 24 h and 48 h, and the differences were statistically significant (P < 0.05). The tumor volume and wet weight of the miR-9-5p overexpression group were significantly higher than those of the control group, and the differences were statistically significant (P < 0.05). The protein level of UBE4B in the miR-9-5p overexpression group was lower than that in the control group, and the difference was statistically significant (P < 0.05); the expression of HIF1α and glycolysis-related genes (Glut1, HK2 and LDHA) was significantly higher than that of the control group, and the difference was statistically significant (P < 0.05). Conclusion miR-9-5p can regulate the Warburg effect of gliomas and promote the occurrence and development of gliomas through the UBE4B/HIF1α pathway.
|
|
|
|
|
[1] Poff A,Koutnik AP,Egan KM,et al. Targeting the Warburg effect for cancer treatment:Ketogenic diets for management of glioma [J]. Semin Cancer Biol,2019,56:135-148.
[2] Liang J,Cao R,Zhang Y,et al. PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis [J]. Nat Commun,2016,7:12431.
[3] Liu J,Gao L,Zhan N,et al. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma [J]. J Exp Clin Cancer Res,2020,39(1):137.
[4] Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations [J]. J Clin Invest,2013,123(9):3664-3671.
[5] Weng C,Chen Y,Wu Y,et al. Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53 [J]. Onco Targets Ther,2019,12:2553-2561.
[6] Rupaimoole R,Slack FJ. MicroRNA therapeutics:towards a new era for the management of cancer and other diseases [J]. Nat Rev Drug Discov,2017,16(3):203-222.
[7] Chen X,Yang F,Zhang T,et al. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma [J]. J Exp Clin Cancer Res,2019, 38(1):99.
[8] Zhen J,Zhang H,Dong H,et al. miR-9-3p inhibits glioma cell proliferation and apoptosis by directly targeting FOXG1 [J]. Oncol Lett,2020,20(2):2007-2015.
[9] Du P,Liao Y,Zhao H,et al. ANXA2P2/miR-9/LDHA axis regulates Warburg effect and affects glioblastoma proliferation and apoptosis [J]. Cell Signal,2020,74:109718.
[10] 于子页,徐铭,徐宏治.中枢神经系统胆固醇代谢及其对脑胶质瘤免疫治疗的作用[J].中国临床神经科学,2021, 29(1):88-95.
[11] 张鹏博,刘畅,张庆梅,等.胶质瘤中MAGE基因的生物信息学筛选分析及实验初步验证[J].基层医学论坛,2021,25(1):1-4.
[12] Ma L,Young J,Prabhala H,et al. miR-9,a MYC/MYCN-activated microRNA,regulates E-cadherin and cancer metastasis [J]. Nat Cell Biol,2010,12(3):247-256.
[13] Khachigian LM. The Yin and Yang of YY1 in tumor growth and suppression [J]. Int J Cancer,2018,143(3):460-465.
[14] DA Silva Oliveria CK,Bona AB,DA Silva FJ,et al. Expression of hsa-miR-9 and MYC Copy Number Variation in Hereditary Diffuse Gastric Cancer [J]. Anticancer Res,2017,37(5):2401-2406.
[15] Sun Z,Han Q,Zhou N,et al. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma [J]. Mol Oncol,2013,7(5):884-894.
[16] Ji Q,Li Y,Zhao Q,et al. KLF11 promotes gastric cancer invasion and migration by increasing Twist1 expression [J]. Neoplasma,2019,66(1):92-100.
[17] Memon A,Lee WK. KLF10 as a Tumor Suppressor Gene and Its TGF-beta Signaling [J]. Cancers (Basel),2018, 10(6):161.
[18] Nan Y,Guo H,Guo L,et al. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1alpha/VEGF Signaling Pathway by Targeting CAB39 [J]. Hum Gene Ther Clin Dev,2018,29(3):156-166.
[19] Guo H,Nan Y,Zhen Y,et al. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1 [J]. Tumour Biol,2016,37(10):13751-13761.
[20] Nie S,Li K,Huang Y,et al. miR-495 mediates metabolic shift in glioma cells via targeting Glut1 [J]. J Craniofac Surg,2015,26(2):e155-e158.
[21] Teng Y,Zhang Y,Qu K,et al. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 [J]. Oncotarget,2015,6(38):40799-40814.
[22] Shen S,Yao T,Xu Y,et al. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc [J]. Mol Cancer,2020,19(1):151.
[23] Ma B,Cheng H,Mu C,et al. The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression [J]. Nat Commun,2019,10(1):1034.
[24] 李明彧,马海龙,杨溪,等.癌相关成纤维细胞在肿瘤葡萄糖代谢中的作用[J].中国口腔颌面外科杂志,2021, 19(1):70-75.
[25] 孟云,沈影,郭滢,等.基于中医“阳化气”理论探讨HIF-1与能量代谢在复发性卵巢癌治疗中的意义[J].中医药学报,2021(4):4-7. |
|
|
|